申请人:AMOREPACIFIC CORPORATION
公开号:US10696611B2
公开(公告)日:2020-06-30
Disclosed is a novel adamantine derivative compound, an isomer thereof, pharmaceutically acceptable salt thereof, prodrug thereof, hydrate thereof or a solvate thereof. Also disclosed is a method for preparing a novel adamantine derivative compound, an isomer thereof, pharmaceutically acceptable salt thereof, prodrug thereof, hydrate thereof or a solvate thereof. The novel adamantane derivative compound or the like has an excellent anti-androgenic effect.
公开了一种新型
金刚烷衍
生物化合物、其异构体、其药学上可接受的盐、其原药、其
水合物或其溶液。还公开了一种制备新型
金刚烷衍
生物化合物、其异构体、其药学上可接受的盐、其原药、其
水合物或其溶液的方法。新型
金刚烷衍
生物化合物或类似物具有优异的抗雄激素作用。